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Exercise is known to affect the airway epithelium through dehydration, followed by a release
of mediators, such as club cell (Clara) protein (CC16). The aim of this study was to follow the
CC16 levels at repeated time points in plasma and urine after exercise in asthmatic subjects
and controls, and to relate the findings to exhaled breath temperature (EBT) and exhaled nitric
oxide (NO).
Twenty-two asthmatics and 18 healthy subjects performed an exercise challenge test on a
treadmill. Lung function, CC16 in plasma and urine, EBT and fractional exhaled NO were inves-
tigated before and repeatedly for 60 min after the exercise.
The increase in CC16 concentration in plasma was seen already one minute after exercise
(p < 0.001) and increased further after 20 (p Z 0.009) until 60 min (p Z 0.001). An increase
in urinary levels of CC16 peaked after 30 min (p < 0.001), and declined after 60 min but were
still higher than baseline (pZ 0.002). There were no differences in plasma or urine CC16 levels
between asthmatics and controls, but males had higher plasma levels compared to females
(p < 0.001) at all time points. EBT peaked at 15 min (p < 0.001) and thereafter declined,
and FENO50 (p < 0.0001), alveolar NO concentration (p Z 0.049) and bronchial flux of NO
(p Z 0.0055) decreased after exercise.
In conclusion, this study shows that CC16 in plasma increased during 60 min after exercise,
not synchronized with CC16 levels in urine. CC16 levels in plasma correlated to EBT and222 78 28.
ed.lu.se (E. Tufvesson).
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1676 E. Tufvesson et al.exhaled NO, reflecting an overall epithelial involvement. There was no difference between
asthmatics and healthy controls, showing a physiological rather than pathophysiological
response.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Exercise is known to affect the airway epithelium, and
trigger an exercise-induced bronchoconstriction (EIB) due
to the cooling and osmotic effects caused by airway dehy-
dration [1]. The prevalence of asthma and EIB is markedly
increased in elite athletes [2], and are most probably due
to an epithelial injury arising from breathing poorly condi-
tioned air at high flows for long periods of time [3]. Evap-
orative water loss from the airway surface, in conditioning
the inspired air, is believed to be the stimulus for exercise-
induced bronchoconstriction. An acute effect of this
dehydration is the release of mediators which can stimulate
smooth muscle contraction or protect the airways [4,5].
An important factor that is involved in this process is
club cell (Clara) protein (CC16), a protein secreted pri-
marily from the club cells (Clara) which are found pre-
dominantly in the terminal bronchioles [6]. CC16 is
suggested to be a protective mediator in the airway in-
flammatory process [7,8]. In the airways of asthmatics,
fewer CC16-positive epithelial cells have been found
compared to controls [9]. The number of CC16 containing
cells in the respiratory mucosa correlates with levels found
in plasma [10], and lower levels of CC16 in serum from
asthmatic children [11] and adults [9,12] have been shown
accordingly. There are also studies showing polymorphism
in the CC16 gene associated with asthma [13e15]. We have
previously shown that epithelial stress occurs during exer-
cise by demonstrating that CC16 is increased in urine after
exercise [16,17] and eucapnic voluntary hyperventilation
[18] in athletes. The levels of CC16 are also known to in-
crease in serum after exercise [19e21]. However, even
though CC16 is known to increase both in serum and in
urine, a more detailed time kinetic view is lacking. Thus by
frequent sampling closely after exercise it might be
possible to clarify if the increase in CC16 levels in plasma is
due to direct epithelial leakage or increased secretion/
production. Whether the increase in CC16 is due to the
osmotic stress and/or the mechanical stress generated
within the airways when large quantities of unconditioned
air are inhaled remains unknown. However, we know that it
is dependent on inspired air conditions and is more abun-
dant in dry compared to humid air [16].
The aim of this study was thus to investigate the
epithelial involvement during exercise by repeatedly mea-
sure the levels of CC16 in plasma and urine in asthmatic
subjects and healthy controls. Levels of CC16 in urine have
previously shown very large individual variations, and by
using complementary plasma levels we aimed to minimize
these variations and possibly detect more distinct differ-
ences between asthmatics and healthy controls. With a
tight schedule of plasma sampling we wanted to investigate
a detailed time kinetic of the CC16 response after exercise.A secondary aim was to investigate how exercise affects the
relation between CC16 involvement, exhaled breath tem-
perature (EBT) and exhaled nitric oxide (NO).
Materials and methods
Subjects
Twenty-two subjects with mild asthma according to Gina
guidelines [22] and regular asthma symptoms were inves-
tigated (Table 1). Eighteen healthy subjects without res-
piratory symptoms or diagnosed asthma were used as
controls. All subjects were non-smokers without respiratory
tract infection within three weeks prior to the investiga-
tion. Caffeine was withheld two hours prior to the investi-
gation, strenuous physical exercise was not allowed on the
same day, and no form of exhausting mean of trans-
portation to get to the laboratory was allowed. All asth-
matic subjects refrained from using b2-agonists and inhaled
corticosteroids for at least 48 h before the study. No sub-
jects were on anti-leukotriene treatment. The study was
approved by the Regional Ethical Review board of Lund, and
all subjects gave informed consent.
Study design
At arrival in the clinic, participants emptied their bladder
and were asked to drink a glass of water. Thereafter,
exhaled NO was measured, spirometry performed and blood
sample, temperatures and urine sample were taken. Four
ECG leads were used to measure the heart rate throughout
the exercise challenge test. The subjects were not allowed
to warm up beforehand. The exercise challenge test was
divided into three phases (aec) conducted on a treadmill:
a) during the first two minutes of running, speed and level
of upward slope were set to increase the heart rate of the
subject to approximately 90% of calculated maximum ca-
pacity (defined as 220 beats per minute e age in years), b)
the speed and level of upward slope were adjusted to keep
the subject’s heart rate steady at that level for four mi-
nutes, c) during the last two minutes, the speed and level
of upward slope were increased to push the subject’s heart
rate above the level of the previous phases, and induce a
maximum exertion. Hereafter, the subjects were resting for
60 min while blood and urine samples were taken,
spirometry performed and EBT, oral and auricular temper-
atures were measured repeatedly as described below.
Flow-volume spirometry (Jaeger MasterScope, Wu¨zburg,
Germany) measuring FEV1 was performed three times
before (baseline) and once 5, 10, 15, 20, 30, 45 and
60 min after the exercise challenge test. FEV1% predicted
(%p) was calculated according to Crapo [23].
Table 1 Patient characteristics and exhaled NO levels at







Sex, male/female 9/9 12/10
Age, years 25 (22e35) 26 (24e33)
FEV1, l 4.0 (3.3e4.7) 3.8 (2.9e4.5)




Fall in FEV1 during
test, %
4.6 (0e6.8) 6.1 (3.0e18.8)
Atopy, n 4 12




15.8 (9.5e35.1) 21.8 (15.1e37.3)
FENO50 post
exercise, ppb
13.1 (7.7e35.9)* 18.8 (11.2e27.7)***
CANO, baseline,
ppb
2.7 (2.1e3.6) 3.2 (2.3e5.0)
CANO post
exercise, ppb
2.6 (1.8e3.2) 2.6 (1.9e3.3)
J’awNO baseline,
nl/s
1.0 (0.3e1.8) 0.9 (0.6e1.5)
J’awNO post
exercise, nl/s
0.7 (0.3e1.7)* 0.9 (0.5e1.3)
Data are shown as median (IQR). FEV1 Z forced expiratory
volume in 1 s, ICS Z inhaled corticosteroids, FENO50 Z frac-
tional exhaled NO at flow 50 ml/s, CANO Z alveolar NO con-
centration, J’awNO Z bronchial flux of NO, * Z flagging
statistical difference compared to corresponding baseline (*p <
0.05, ***p < 0.001).
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Baseline plasma and urine samples were collected just prior
to the exercise test. Following completion of the exercise
tests, plasma samples were collected after 1, 5, 10, 15, 20,
30, 45 and 60 min, and urine samples were collected after
30 and 60 min. Because CC16 is also produced in small
amounts in the male urogenital tract, the first 100 ml of
each male urine collection was discarded in the present
study, to minimize contamination [24]. All samples were
stored at80 C and analysed within two months [21]. CC16
was measured using the Human Clara Cell Protein ELISA kit
from BioVendor (Modrice, Czech Republic). All urine sam-
ples were corrected for creatinine. Urine levels of creati-
nine, albumin, immunoglobulin G and protein HC were
measured at the Clinical Chemistry at Lund University
Hospital, using a COBAS 6000 system.
Exhaled breath temperature
Exhaled breath temperature was measured in a sub fraction
of the subjects (n Z 23; 16 asthmatics and 7 non-
asthmatics; 15 males and 8 females, same FEV1 %p, exer-
cise response, CC16 levels and NO levels as the total studypopulation), using an Xhalo (Delmedica Investments,
Singapore), before and 15, 30, 45 and 60 min after the
exercise challenge test. Subjects were instructed to
breathe tidally, inhaling through the nose and exhaling
through the mouth into the device. Measurements took
1e5 min to complete.
Oral and auricular temperatures were measured once
before and 15, 30, 45 and 60min after the exercise challenge
test.
Exhaled nitric oxide concentration
NO measurements were performed using a NIOX Flex
(Aerocrine, AB, Stockholm, Sweden). Patients were
comfortably seated; inhaled NO depleted ambient air, and
exhaled at different flow rates (50 (giving FENO50), 100, 200
and 300 ml/s) 3e4 times. Alveolar NO concentration (CANO)
and bronchial NO flux (J’awNO) was approximated by
plotting NO-output against exhaled flow (at 100e300 ml/s).
The slope and intercept of this linear regression approxi-
mated CANO and J’awNO, respectively [25,26].
Statistical analyses
All statistical calculations were performed using SPSS 21.0
for Windows (SPSS, Inc., Chicago, IL). CC16 results followed
Gaussian distribution (ShapiroeWilks test) and are there-
fore presented as mean (SEM), and statistical analyses were
done using parametric tests (unpaired and paired t-test).
All other results and correlations are expressed as median
(interquartile range (IQR)), and statistical analyses were
done using non-parametric tests (ManneWhitney test for
unpaired data, Wilcoxon’s test for paired data and corre-
lations were calculated by Spearman’s correlation test).
Unpaired tests were used for comparing cases (asthmatics
versus healthy, males versus females, etc) and paired tests
were used to compare repeated measures of CC16, EBT and
exhaled NO. A p-value of <0.05 was considered significant.
Results
Exercise test
Nine asthmatics and one control subject had a positive
exercise test (defined as a fall in FEV1 10%). There were
no significant differences between asthmatics and healthy
controls (or between asthmatics on ICS treatment
compared to those who were not on ICS treatment)
regarding age, sex, baseline FEV1, FEV1 %p or fall in FEV1
after the exercise test (Table 1).
CC16 in plasma and urine
There was an increase in CC16 concentration in plasma
already one minute after the exercise test compared to
baseline (p < 0.001) in all samples (Fig. 1A). These higher
levels thereafter remained and increased further after 20
(pZ 0.009) until 60 min (pZ 0.001). No difference between
asthmatics and controls was seen, nor between all subjects
whohadapositiveexercise test (including thehealthycontrol
subject with a positive exercise test) and those who did not.
Figure 1 CC16 concentrations in plasma (A, C) and urine (B, D) at baseline (pre) and 1e60 min after exercise challenge in (A, B) in
asthmatics (-) and healthy controls (,) and in (C, D) in males (C) and females (B). CC16 levels in urine were corrected for
creatinine levels. * Z p < 0.05, ** Z p < 0.01 and *** Z p < 0.001 show significance compared to baseline, and yyy Z p < 0.001
show significant difference between males and females.
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of CC16 at 30 min after the exercise test (p < 0.001), which
decreased after 60 min (p < 0.001 compared to 30 min) but
was still higher than baseline (p Z 0.002). Similar to
plasma, there were no differences in urine levels of CC16
between asthmatics and controls (Fig. 1B).
There were no correlations between fall in FEV1 and
CC16 levels in either plasma or urine.
Interestingly, males had significantly higher plasma
levels of CC16 compared to females (p < 0.001) at all time
points (Fig. 1C). However, there were no differences be-
tween males and females in relative increase (values at
each time point divided by baseline values) in CC16 levels.
No similar differences could be seen in urine levels of CC16
between males and females (Fig. 1D).
Exhaled breath temperature
There was an increase in EBT from baseline to 15 min
(p < 0.001). The temperature thereafter declined, but
remained higher than baseline for 45 min (Fig. 2A). No
difference in EBT was seen between asthmatics and
healthy controls, or between males and females, and there
was no correlation between fall in FEV1 and EBT at any time
point.
A correlation was seen between CC16 levels in plasma
10e45 min after the test and DEBT (Zdefined as thedifference between baseline EBT and the highest EBT after
the exercise challenge), (pZ 0.027e0.049; rZ 0.48e0.42)
(Fig. 2B). In addition, a reverse correlation was seen be-
tween all relative CC16 values in plasma from 1 to 60 min
and EBT at 60 min after exercise (p Z 0.011e0.034,
r Z 0.56 to 0.46).
Exhaled NO
Overall there was a lowering of exhaled NO levels after
exercise. When including all subjects there was a decrease
in FENO50 (p < 0.0001), CANO (p Z 0.049) and J’awNO
(p Z 0.0055) after exercise. After subdivision into healthy
controls and asthmatics (Table 1), both groups showed a
significant reduction in FENO50 (healthy controls: pZ 0.021
and asthmatics: p Z 0.001), and the controls in J’awNO
(pZ 0.019) and asthmatics closely in CANO (pZ 0.058). No
significant differences in FENO50, CANO or J’awNO could be
seen between healthy controls and asthmatics.
Correlations between all relative CC16 values in plasma
from 5 to 60 min and the differences in FENO50 from
baseline to post-exercise (DFENO50) were seen (p-values
ranging from 0.004 to 0.041 and r-values ranging from 0.48
to 0.39). Furthermore, CC16 levels in plasma from 10 to
60 min after the test and DCANO correlated significantly (p-
values ranging from 0.004 to 0.023 and r-values ranging
from 0.48 to 0.38).
Figure 2 (A) EBT in all subjects baseline (pre) and 15e60 min
after exercise challenge. (B) Correlation between DEBT
(Zdefined as the difference in EBT from baseline to the
highest EBT after exercise challenge) and CC16 concentrations
in plasma at 15 min after exercise. ** Z p < 0.01 and
*** Z p < 0.001 show significance compared to baseline.
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This is the first study comparing plasma to urine response in
CC16 after exercise. This study showed that CC16 levels in
plasma were increased directly after exercise, and
continued to increase during at least 1 h. No difference in
CC16 levels could be seen between asthmatics and healthy
controls, but males showed higher levels than females.
CC16 levels in urine peaked 30 min after exercise, declined
close to baseline levels after 60 min, and did not differ
between asthmatics and healthy controls or between males
and females. In addition, CC16 levels in plasma after ex-
ercise correlated to both an increase in EBT and decreases
in total exhaled and alveolar NO levels.
No difference in CC16 levels could be seen between
asthmatics and healthy controls, which may be due to the
response being physiological rather than pathophysiolog-
ical. CC16 is suggested to be a protective mediator in theairway inflammatory process, but could serve as a pro-
tective mechanism during exercise induced by airway
epithelial water loss independently of concurrent inflam-
mation, i.e. asthma. Mild asthmatics and healthy control
subjects are investigated in this study, and it is possible
that more severe asthmatics, assumed to have a greater
degree of airway epithelial damage at baseline, would
behave differently. Additionally, type of regular sport
activity may affect epithelial conditions, and especially
swimmers’ epithelia and CC16 levels are known to be
altered [27,28]. In our study, the majority of the subjects
were endurance sport athletes, mostly runners and
floorball players, and only one swimmer (healthy control)
was included. We therefore believe that our subject
population was rather homogenous in the context of
epithelial damage.
Possible explanations for a CC16 increase in plasma are
leakage through increased permeability in the airway
epithelium, increased production/secretion of CC16 in the
lung or reduced renal clearance. Most probably, there is a
direct exercise induced effect on the epithelium caused by
dehydration. It has previously been shown that increased
microvascular permeability after exercise is related to the
severity of EIB [29]. However, in our study there was no
difference between asthmatics and healthy controls, which
may suggest that the increase in CC16 in plasma would not
only be due to increased leakage over the epithelium.
An interesting finding was the higher levels of CC16 in
plasma from males compared to females, while the relative
increase of CC16 was the same after exercise. The reason
for this is not known, but may be due to an alternative
source in males. CC16 is known to be produced in the
prostate, but an increase in CC16 levels would then most
probably be seen in male’s urine which was not the case. A
higher relative amount of club cells (Clara) in male lungs,
not directly related to lung function within sexes, could
explain the larger absolute increase (Fig. 1C).
The increase of CC16 in plasma was in fact larger than
directly measured, because a portion of CC16 was excreted
in the urine. About 40 ng CC16/ml urine was lost during the
first hour, and estimated calculations show that this cor-
responded to about 2 ng/ml CC16 in plasma (based on
about 300 ml urine). The levels of CC16 in Fig. 1A should
thereby be elevated about 2 ng/ml during the first part of
the curve, giving another pattern of earlier increase going
into a stable phase prior to what could directly be
measured in plasma.
The portion of CC16 excreted in the urine was the same
in males and females. Urinary excretion did therefore not
explain the gender differences in plasma levels. Moreover,
sputum and BAL levels of CC16 have been measured in
another study, revealing no differences between males and
females (unpublished data). The amount of CC16 secreted
into the airway lumen was therefore most probably not
depending on sex. In addition, no difference in EBT was
seen between males and females, as shown both in this
study and in a previous study [30]. This reflects a sex
neutral epithelial effect, at least regarding perfusion.
The urine levels of CC16 displayed large inter-individual
differences after exercise, which has been observed also in
previous publications [16,18]. Because this could be due to
differences in glomerular properties, the urine specimens
1680 E. Tufvesson et al.from a subfraction of the subjects (n Z 13) were also
analysed for clinical glomerular markers, such as albumin,
immunoglobulin G and protein HC (Zalpha-1-
microglobulin). None of these markers differed between
males and females, or between asthmatics and healthy
controls. All markers were increased 30 min after exercise.
Most prominently albumin increases, similarly to CC16,
confirming that exercise per se increases glomerular
permeability, being the main reason for high CC16 levels in
urine [31]. The minor increase in protein HC demonstrates
that the effect is not due to changes in tubular reabsorp-
tion. Another interesting point is that the molecular weight
of CC16 is close to the glomerular threshold for protein
filtration. In this study, the relative increase in CC16 was
significantly higher than albumin, immunoglobulin G and
protein HC and therefore more sensitive to changes in
glomerular permeability. This closeness to glomerular
threshold may be the explanation for the large inter-
individual changes in urinary CC16 levels. In addition, the
increase in plasma CC16 was thereby not an effect of
reduced renal clearance.
EBT has previously been shown to increase after exer-
cise [30,32], which is demonstrated also in this study. In
addition, the correlation between CC16 levels in plasma
and the increase in EBT after exercise demonstrate a link
between epithelial effect and an increase in perfusion. In
this study, EBT was measured in only a sub fraction of the
subjects (matched for FEV1 %p, exercise response, CC16
levels and NO levels), but because there was no gender
difference in EBT or difference between asthmatics and
healthy subjects in EBT (also reported previously [30]), the
smaller group of subjects most probably reflect the total
study population.
Overall, there were decreases in all exhaled NO pa-
rameters after exercise. This has been observed earlier for
FENO50 [33,34], but not investigated for CANO and J’awNO.
A possible explanation is the increased ventilation of the
airways. Exhaled NO is to a large extent produced by the
airway epithelium, and a correlation between DFENO50 and
all relative CC16 values in plasma from 5 to 60 min, shown
in this study, suggest an overall related epithelial effect. In
addition, DCANO correlated to the CC16 levels in plasma,
which might also be due to the epithelial effect giving rise
to a narrowing of the airways thereby impeding the out-
flow of the alveolar air.
In conclusion, this study shows that CC16 had an
increasing pattern in plasma 1e60 min after exercise,
together with an increase in urine after 30 min. The in-
crease in plasma may be due to both an altered pulmonary
epithelial permeability after intense exercise, as well as
increased production/secretion of CC16 from the club cells
(Clara). These plasma levels were higher in males compared
to females, while the relative increase of CC16 was the
same. The large inter-individual variation in urine levels of
CC16 was most probably due to individual differences in
increased glomerular permeability. In addition, EBT was
increased and exhaled NO was decreased following exer-
cise, and correlations to CC16 levels in plasma were most
probably reflecting an overall epithelial involvement. There
was no difference in CC16 levels between asthmatics and
healthy controls, showing a physiological rather than
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